https://defra.bravosolution.co.uk/web/login.html

The Authority on behalf the APHA is looking to appoint a Contract Manufacturing Organisation (CMO) to produce the fusion protein (DST-F) to the standards of UK Good Manufacturing Practice (GMP).This will involve technology transfer from the current non-GMP manufacturer of the manufacturing steps and quality control tests for all stages of production from Master Seed (MS) through to testing and release of a finished commercial product. The CMO will have the capacity for the anticipated commercial scale manufacture of up to one million doses annually